Adaptive Biotechnologies lobbies on its own behalf. For Q1 2022 it reported $240K across 1 client report and lists 1 lobbyist across its filings. Issues include Medicare/Medicaid and Health Issues.
| Client | Reported | Issues |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES | $240K | Medicare/Medicaid, Health Issues |
| Year | Reported | Clients |
|---|---|---|
| 2022 | $240K | 1 |
| 2021 | $580K | 1 |
| 2020 | $190K | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.